| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biogen Inc. (BIIB) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. BIIB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 19.8K | $4.09M | - | |
| Other | 5.8K | $1.19M | - | |
| Other | 2.1K | $439.0K | - | |
| Other | 503 | $103.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 1, 2015 | Scangos George A77 | Chief Executive Officer | Sell | 1,362 | $377.52 | $514,182.24 | -3.1% | |
| Apr 1, 2015 | Scangos George A77 | Chief Executive Officer | Sell | 1,362 | $423.20 | $576,398.40 | -3.0% | |
| Mar 27, 2015 | Sandrock Alfred69 | Grp SVP, Chief Medical Officer | Sell | 430 | $430.12 | $184,951.60 | -4.8% | |
| Mar 25, 2015 | Cox John | EVP Pharmaceutical Oper &Tech | Sale+OE | 12,010 | $449.06 | $5,393,210.60 | -32.0% | |
| Mar 20, 2015 | Rowinsky Eric K | Director | Sale+OE | 11,667 | $475.00 | $5,541,825.00 | -50.8% | |
| Mar 19, 2015 | Rowinsky Eric K | Director | Sale+OE | 2,333 | $436.14 | $1,017,507.62 | -17.1% | |
| Mar 17, 2015 | Rowinsky Eric K | Director | Sale+OE | 4,667 | $425.45 | $1,985,589.15 | -29.2% | |
| Mar 16, 2015 | Dipietro Kenneth | EVP Human Resources | Sell | 803 | $415.46 | $333,614.38 | -100% | |
| Mar 13, 2015 | Scangos George A77 | Chief Executive Officer | Sell | 537 | $412.69 | $221,613.46 | -1.2% | |
| Mar 10, 2015 | Pangia Robert W | Director | Sale+OE | 3,625 | $413.40 | $1,498,577.78 | -2.5% |